SG11201400945UA - Humanized il-6 and il-6 receptor - Google Patents

Humanized il-6 and il-6 receptor

Info

Publication number
SG11201400945UA
SG11201400945UA SG11201400945UA SG11201400945UA SG11201400945UA SG 11201400945U A SG11201400945U A SG 11201400945UA SG 11201400945U A SG11201400945U A SG 11201400945UA SG 11201400945U A SG11201400945U A SG 11201400945UA SG 11201400945U A SG11201400945U A SG 11201400945UA
Authority
SG
Singapore
Prior art keywords
humanized
receptor
Prior art date
Application number
SG11201400945UA
Inventor
Li-Hsien Wang
Jr Anthony T Dore
Sean Stevens
Andrew J Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of SG11201400945UA publication Critical patent/SG11201400945UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201400945UA 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor SG11201400945UA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552900P 2011-10-28 2011-10-28
US201161556579P 2011-11-07 2011-11-07
PCT/US2012/062379 WO2013063556A1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Publications (1)

Publication Number Publication Date
SG11201400945UA true SG11201400945UA (en) 2014-04-28

Family

ID=47295138

Family Applications (3)

Application Number Title Priority Date Filing Date
SG11201400945UA SG11201400945UA (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor
SG10202100485XA SG10202100485XA (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor
SG10201600965YA SG10201600965YA (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Family Applications After (2)

Application Number Title Priority Date Filing Date
SG10202100485XA SG10202100485XA (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor
SG10201600965YA SG10201600965YA (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Country Status (28)

Country Link
US (9) US8878001B2 (en)
EP (2) EP2818478B1 (en)
JP (2) JP6120451B2 (en)
KR (2) KR102084927B1 (en)
CN (2) CN108866101A (en)
AU (1) AU2015207889B2 (en)
BR (1) BR112014008529A2 (en)
CA (1) CA2853731C (en)
CY (2) CY1116614T1 (en)
DK (2) DK2818478T3 (en)
ES (2) ES2525368T3 (en)
HK (2) HK1190408A1 (en)
HR (2) HRP20141192T1 (en)
HU (1) HUE033400T2 (en)
IL (4) IL231896B (en)
IN (1) IN2014CN03920A (en)
LT (1) LT2818478T (en)
MX (1) MX358390B (en)
MY (2) MY172726A (en)
PL (2) PL2663575T3 (en)
PT (2) PT2818478T (en)
RS (2) RS55949B1 (en)
RU (2) RU2751240C2 (en)
SG (3) SG11201400945UA (en)
SI (2) SI2818478T1 (en)
SM (1) SMT201400187B (en)
WO (1) WO2013063556A1 (en)
ZA (1) ZA201402635B (en)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3056082B1 (en) 2009-10-06 2018-09-05 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
ES2948210T3 (en) 2011-02-15 2023-09-06 Regeneron Pharma Mice humanized with M-CSF and their use
EP2818478B1 (en) 2011-10-28 2017-02-01 Regeneron Pharmaceuticals, Inc. Humanized IL-6 and IL-6 receptor
US20130261016A1 (en) * 2012-03-28 2013-10-03 Meso Scale Technologies, Llc Diagnostic methods for inflammatory disorders
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
KR102340059B1 (en) 2012-09-07 2021-12-17 예일 유니버시티 Genetically modified non-human animals and methods of use thereof
WO2014042251A1 (en) * 2012-09-13 2014-03-20 中外製薬株式会社 Gene knock-in non-human animal
MX370856B (en) 2012-11-05 2020-01-08 Regeneron Pharma Genetically modified non-human animals and methods of use thereof.
KR102211267B1 (en) 2013-02-22 2021-02-04 리제너론 파아마슈티컬스, 인크. Mice expressing humanized major histocompatibility complex
GB2513884B (en) 2013-05-08 2015-06-17 Univ Bristol Method and apparatus for producing an acoustic field
LT3175706T (en) * 2013-09-23 2019-02-25 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized signal-regulatory protein gene
ES2613379T3 (en) * 2013-10-15 2017-05-24 Regeneron Pharmaceuticals, Inc. Animals with humanized IL-15
JP6484237B2 (en) 2013-11-19 2019-03-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． Non-human animals having humanized growth-inducing ligand genes
AU2014353346B2 (en) 2013-11-19 2020-05-14 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized B-cell activating factor gene
US9612658B2 (en) 2014-01-07 2017-04-04 Ultrahaptics Ip Ltd Method and apparatus for providing tactile sensations
JP6511459B2 (en) 2014-01-31 2019-05-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Novel anti-BAFF antibody
KR102223264B1 (en) 2014-04-08 2021-03-09 리제너론 파아마슈티컬스, 인크. Non-human animals having humanized fc-gamma receptors
MX2016014504A (en) 2014-05-05 2017-05-23 Regeneron Pharma Humanized c5 and c3 animals.
NO2785538T3 (en) 2014-05-07 2018-08-04
SG10202002187WA (en) 2014-05-19 2020-04-29 Regeneron Pharma Genetically modified non-human animals expressing human epo
MX2020004803A (en) * 2014-05-30 2021-10-13 Regeneron Pharma Humanized dipeptidyl peptidase iv (dpp4) animals.
MX2016016903A (en) * 2014-06-19 2017-03-27 Regeneron Pharma Non-human animals having a humanized programmed cell death 1 gene.
GB2530036A (en) 2014-09-09 2016-03-16 Ultrahaptics Ltd Method and apparatus for modulating haptic feedback
SI3223605T1 (en) 2014-11-24 2021-03-31 Regeneron Pharmaceuticals, Inc. Non-human animals expressing humanized cd3 complex
NZ731471A (en) * 2014-12-05 2021-12-24 Regeneron Pharma Non-human animals having a humanized cluster of differentiation 47 gene
ES2908299T3 (en) 2015-02-20 2022-04-28 Ultrahaptics Ip Ltd Algorithm improvements in a haptic system
EP3916525A1 (en) 2015-02-20 2021-12-01 Ultrahaptics IP Limited Perceptions in a haptic system
MX2017012829A (en) 2015-04-06 2018-02-23 Regeneron Pharma Humanized t cell mediated immune responses in non-human animals.
RU2730599C2 (en) 2015-04-13 2020-08-24 Ридженерон Фармасьютикалз, Инк. Humanised mice with sirpa-il15 nokin and methods for using them
US10818162B2 (en) 2015-07-16 2020-10-27 Ultrahaptics Ip Ltd Calibration techniques in haptic systems
MX2018005389A (en) 2015-11-20 2018-09-05 Regeneron Pharma Non-human animals having a humanized lymphocyte-activation gene 3.
HUE052155T2 (en) 2015-12-08 2021-04-28 Regeneron Pharma Compositions and methods for internalizing enzymes
US11189140B2 (en) 2016-01-05 2021-11-30 Ultrahaptics Ip Ltd Calibration and detection techniques in haptic systems
CN108779159B (en) 2016-02-04 2022-12-30 瑞泽恩制药公司 Non-human animals with engineered ANGPTL8 genes
US10070632B2 (en) 2016-02-29 2018-09-11 Regeneron Pharmaceuticals, Inc. Rodents having a humanized TMPRSS gene
CN113907043B (en) 2016-06-03 2023-08-01 瑞泽恩制药公司 Non-human animals expressing exogenous terminal deoxynucleotidyl transferase
US10531212B2 (en) 2016-06-17 2020-01-07 Ultrahaptics Ip Ltd. Acoustic transducers in haptic systems
US10268275B2 (en) 2016-08-03 2019-04-23 Ultrahaptics Ip Ltd Three-dimensional perceptions in haptic systems
US10755538B2 (en) 2016-08-09 2020-08-25 Ultrahaptics ilP LTD Metamaterials and acoustic lenses in haptic systems
CN107815467B (en) 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Preparation method and application of humanized gene modified animal model
US10943578B2 (en) 2016-12-13 2021-03-09 Ultrahaptics Ip Ltd Driving techniques for phased-array systems
US10497358B2 (en) 2016-12-23 2019-12-03 Ultrahaptics Ip Ltd Transducer driver
WO2018177441A1 (en) * 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
CN108588126B (en) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Preparation method and application of humanized modified animal model of CD47 gene
AU2018338790B2 (en) 2017-09-29 2022-09-15 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized TTR locus and methods of use
US11531395B2 (en) 2017-11-26 2022-12-20 Ultrahaptics Ip Ltd Haptic effects from focused acoustic fields
SG11202002456WA (en) 2017-11-30 2020-04-29 Regeneron Pharma Non-human animals comprising a humanized trkb locus
US11360546B2 (en) 2017-12-22 2022-06-14 Ultrahaptics Ip Ltd Tracking in haptic systems
EP3729418A1 (en) 2017-12-22 2020-10-28 Ultrahaptics Ip Ltd Minimizing unwanted responses in haptic systems
AU2019242586A1 (en) 2018-03-26 2020-10-01 Regeneron Pharmaceuticals, Inc. Humanized rodents for testing therapeutic agents
SG11202010752VA (en) 2018-05-02 2020-11-27 Ultrahaptics Ip Ltd Blocking plate structure for improved acoustic transmission efficiency
WO2020018511A1 (en) * 2018-07-16 2020-01-23 Regeneron Pharmaceuticals, Inc. Non-human animal models of ditra disease and uses thereof
US11098951B2 (en) 2018-09-09 2021-08-24 Ultrahaptics Ip Ltd Ultrasonic-assisted liquid manipulation
US11378997B2 (en) 2018-10-12 2022-07-05 Ultrahaptics Ip Ltd Variable phase and frequency pulse-width modulation technique
WO2020141330A2 (en) 2019-01-04 2020-07-09 Ultrahaptics Ip Ltd Mid-air haptic textures
CN114107385A (en) * 2019-01-17 2022-03-01 百奥赛图(北京)医药科技股份有限公司 Humanized transgenic animal
SG11202108454RA (en) 2019-04-04 2021-09-29 Regeneron Pharma Non-human animals comprising a humanized coagulation factor 12 locus
US11842517B2 (en) 2019-04-12 2023-12-12 Ultrahaptics Ip Ltd Using iterative 3D-model fitting for domain adaptation of a hand-pose-estimation neural network
EP3978607A4 (en) * 2019-05-27 2023-01-25 Transgenic Inc. Exon-humanized mouse
KR20220016869A (en) 2019-06-04 2022-02-10 리제너론 파마슈티칼스 인코포레이티드 Non-Human Animals Comprising a Humanized TTR Locus with Beta-Slip Mutations and Methods of Use
MX2021015122A (en) 2019-06-07 2022-04-06 Regeneron Pharma Non-human animals comprising a humanized albumin locus.
CA3154040A1 (en) 2019-10-13 2021-04-22 Benjamin John Oliver LONG Dynamic capping with virtual microphones
US11374586B2 (en) 2019-10-13 2022-06-28 Ultraleap Limited Reducing harmonic distortion by dithering
US11169610B2 (en) 2019-11-08 2021-11-09 Ultraleap Limited Tracking techniques in haptic systems
CN111304246B (en) * 2019-12-17 2021-05-04 百奥赛图江苏基因生物技术有限公司 Humanized cytokine animal model, preparation method and application
US11715453B2 (en) 2019-12-25 2023-08-01 Ultraleap Limited Acoustic transducer structures
US20210227812A1 (en) * 2020-01-28 2021-07-29 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
US20230172170A1 (en) 2020-04-21 2023-06-08 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cxcl13 gene
US11816267B2 (en) 2020-06-23 2023-11-14 Ultraleap Limited Features of airborne ultrasonic fields
WO2022058738A1 (en) 2020-09-17 2022-03-24 Ultraleap Limited Ultrahapticons
WO2024073679A1 (en) 2022-09-29 2024-04-04 Regeneron Pharmaceuticals, Inc. Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2202549C (en) * 1994-10-14 2003-08-05 Tara Seshadri Transgenic nonhuman animal having functionally disrupted interleukin-1.beta. converting enzyme gene
EP0791359A4 (en) 1994-10-21 2002-09-11 Chugai Pharmaceutical Co Ltd Remedy for diseases caused by il-6 production
US20030082721A1 (en) * 2001-01-17 2003-05-01 Tai-Jay Chang Transgenic animals expressing androgen receptor complex-associated protein
CN1560081A (en) * 2004-02-17 2005-01-05 大连帝恩生物工程有限公司 Preparing human source monoclone antibody by mouse capable of producing human IgGl weight chain-k light chain and application thereof
DK2767161T3 (en) 2004-10-19 2018-05-07 Regeneron Pharma Method of generating an animal homozygous for genetic modification
US7759541B2 (en) * 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
MX2008014804A (en) 2006-06-02 2009-01-27 Regeneron Pharma High affinity antibodies to human il-6 receptor.
PE20081216A1 (en) * 2006-09-01 2008-09-04 Therapeutic Human Polyclonals Inc ENHANCED EXPRESSION OF HUMAN OR HUMANIZED IMMUNOGLOBULIN IN NON-HUMAN TRANSGENIC ANIMALS
FR2942218A1 (en) 2009-02-13 2010-08-20 Eurocave Sa APPARATUS FOR SERVING GLASS OF A LIQUID, IN PARTICULAR WINE
EP3056082B1 (en) 2009-10-06 2018-09-05 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
SG181690A1 (en) * 2009-12-21 2012-07-30 Regeneron Pharma Humanized fcy r mice
ES2948210T3 (en) 2011-02-15 2023-09-06 Regeneron Pharma Mice humanized with M-CSF and their use
MX366968B (en) * 2011-09-30 2019-08-01 Chugai Pharmaceutical Co Ltd Antigen-binding molecule inducing immune response to target antigen.
CA2852962C (en) 2011-10-28 2022-05-03 Regeneron Pharmaceuticals, Inc. Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules
EP2818478B1 (en) 2011-10-28 2017-02-01 Regeneron Pharmaceuticals, Inc. Humanized IL-6 and IL-6 receptor
RS56656B1 (en) 2011-10-28 2018-03-30 Regeneron Pharma Genetically modified major histocompatibility complex mice

Also Published As

Publication number Publication date
ES2624605T3 (en) 2017-07-17
JP2014532416A (en) 2014-12-08
DK2663575T3 (en) 2014-12-15
IL231896B (en) 2018-02-28
EP2663575B1 (en) 2014-10-01
CA2853731A1 (en) 2013-05-02
RU2751240C2 (en) 2021-07-12
EP2818478B1 (en) 2017-02-01
IL264508B (en) 2019-12-31
HK1205135A1 (en) 2015-12-11
AU2015207889A1 (en) 2015-08-20
ES2525368T3 (en) 2014-12-23
IL264508A (en) 2019-02-28
RS55949B1 (en) 2017-09-29
RU2014121324A (en) 2015-12-10
NZ623145A (en) 2015-09-25
CY1116614T1 (en) 2017-03-15
IL231896A0 (en) 2014-05-28
US20130117873A1 (en) 2013-05-09
CA2853731C (en) 2021-05-18
SI2663575T1 (en) 2015-01-30
RU2017129763A (en) 2019-02-05
KR20200024949A (en) 2020-03-09
RS53683B1 (en) 2015-04-30
PL2663575T3 (en) 2015-03-31
HUE033400T2 (en) 2017-12-28
PT2818478T (en) 2017-05-12
US8878001B2 (en) 2014-11-04
WO2013063556A4 (en) 2013-06-20
WO2013063556A8 (en) 2014-04-17
LT2818478T (en) 2017-06-12
JP6120451B2 (en) 2017-04-26
US9392777B2 (en) 2016-07-19
CN108866101A (en) 2018-11-23
RU2634417C2 (en) 2017-10-26
KR20140091024A (en) 2014-07-18
DK2818478T3 (en) 2017-05-22
ZA201402635B (en) 2015-09-30
HRP20141192T1 (en) 2015-02-13
IL243666B (en) 2019-02-28
SG10201600965YA (en) 2016-03-30
US20150013022A1 (en) 2015-01-08
IL243665A0 (en) 2016-03-31
US20170055506A1 (en) 2017-03-02
RU2017129763A3 (en) 2020-12-18
US9078418B2 (en) 2015-07-14
IL243665B (en) 2018-02-28
US10004211B2 (en) 2018-06-26
US9622460B2 (en) 2017-04-18
US9125386B2 (en) 2015-09-08
IN2014CN03920A (en) 2015-09-04
HRP20170656T1 (en) 2017-06-30
US20150013023A1 (en) 2015-01-08
PT2663575E (en) 2014-12-05
SG10202100485XA (en) 2021-02-25
JP2017035115A (en) 2017-02-16
US20160278352A1 (en) 2016-09-29
HK1190408A1 (en) 2014-07-04
KR102234632B1 (en) 2021-04-02
MX358390B (en) 2018-08-17
EP2818478A1 (en) 2014-12-31
US20220053742A1 (en) 2022-02-24
MY172726A (en) 2019-12-11
US20200008407A1 (en) 2020-01-09
AU2015207889B2 (en) 2017-02-23
IL243666A0 (en) 2016-03-31
EP2663575A1 (en) 2013-11-20
US11102962B2 (en) 2021-08-31
US20180271071A1 (en) 2018-09-27
CN104039821A (en) 2014-09-10
MX2014004900A (en) 2014-08-26
BR112014008529A2 (en) 2017-04-18
PL2818478T3 (en) 2017-09-29
CY1118952T1 (en) 2018-01-10
KR102084927B1 (en) 2020-03-06
NZ709432A (en) 2015-12-24
SI2818478T1 (en) 2017-07-31
US10433528B2 (en) 2019-10-08
WO2013063556A1 (en) 2013-05-02
SMT201400187B (en) 2015-01-15
MY186903A (en) 2021-08-26
US20150272092A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
IL264508B (en) Humanized il-6 and il-6 receptor
HRP20180640T1 (en) Anti-b7-h3 antibody
IL259826A (en) Anti-alphabetatcr antibody
HK1206637A1 (en) Humanized antibodies that recognize alpha synuclein
IL220404A (en) Humanized antibodies
EP2765193A4 (en) Chimeric antigen receptor
HUE051068T2 (en) Interleukin-31 monoclonal antibody
AP2013007135A0 (en) Anti-sclerostin antibody crystals and formulationsthereof
TWI563004B (en) Anti-hxcr1 antibody
ZA201309636B (en) Trough
EP2769988A4 (en) Anti-gap43 antibody
GB201113354D0 (en) Leptin receptor structure